Quick Overview
Guest: Justin Singer, founder and CEO of Caliper Foods and Stillwater Brands, with both legal and business backgrounds, focusing on the cannabis industry.
Main Theme: Regulatory unlocking is the core driver of creating massive market opportunities. The cannabis industry is in the infrastructure-building phase, where dosage and product differentiation will determine brand success or failure.
Core Judgment: Justin Singer believes that the best venture capital opportunity is the intersection of "huge known demand" and "regulatory unlocking events." Technology itself does not create a market; the law must establish the competitive platform.
1. Regulatory Unlocks: The Underlying Logic of Market Creation
Justin Singer argues that every large market can be traced back to a regulatory unlock event, not merely a technological breakthrough. He posits that the most successful investment opportunities in history have often emerged at the intersection of "regulatory unlocks" and "known demand."
- Historical Chain of Evidence: He cites multiple lines of evidence: ① Spectrum auctions (1980s-1990s) opened up the telecom market; ② The inversion of capital gains tax rates relative to ordinary income tax rates triggered a boom in the mutual fund industry; ③ Bankruptcy law reform (high-yield bonds/junk bonds) gave rise to the restructuring and turnaround industry; ④ The passage of the Dietary Supplement Health and Education Act (DSHEA) in 1993 led to explosive growth in the supplement industry. He notes that the commonality across each case is that the law/regulation provided a "platform of certainty," allowing participants to know how the system would operate in different scenarios, thereby giving them the confidence to invest.
- Counterexamples and Falsification Conditions: Using autonomous driving as an example, he argues that technical capability is not the issue, but rather the "insurance problem" and "legal problem" remain unanswered, leading him to be bearish. The falsification condition: Only when a transferable liability insurance framework is established can autonomous driving become a genuine market.
- The "Rules Equal Free Market" Paradox: Singer proposes, "A market without rules is not a free market; it's a jungle where the strong prey on the weak. If you want a free market, go to Russia, where the guy with the biggest gun wins." He draws an analogy to football history: In the late 19th century, college football saw deaths every year until unified rules (first down, receiving, downs) were established, transforming it from a "brawl" into the Super Bowl. Rules are not constraints; they create a shared platform for exchange. He further uses the F1 racing analogy: Every few years, the rules for car construction are changed to prevent teams from widening the gap through extreme optimization of the old rules (that last 5% of marginal effort), forcing all participants back into the "first 95% of innovation space," thereby stimulating competition and economic activity.
2. Cannabis Industry Scan: Two Markets, Three Doses, 50 States
Singer believes that THC and CBD are two completely different industries, each with its own regulatory structure, supply chain, and growth logic. He repeatedly emphasizes that understanding dosage differences is key to understanding the industry.
- Comparison of two market sizes: According to Singer, the U.S. legal THC market is approximately 10-200 hundred million USD, the illegal THC market is approximately 60-700 hundred million USD, and the CBD market is approximately 2-40 hundred million USD (his estimate is on the high side). However, CBD is basically in a "completely unregulated" state, and company self-discipline is ineffective because "the returns from lying far exceed those from integrity."
- Dosage differences: "One compound, three drugs": Singer proposes a quantitative framework—
- Sub-5 mg (microdose): For most people, ≈ mild anti-anxiety/relaxation, does not affect function;
- 5-15 mg (standard dose): Most people begin to "truly get high";
- Above 50 mg (high dose): Approaching hallucinogenic experience, most people unwilling to repeat.
He particularly emphasizes: "Low-dose (1-2 mg) products have no reason to be treated as cannabis; they are not intoxicating doses at all. The 10 mg level should be regulated like alcohol." This view directly challenges the current regulatory framework.
- 50 states, 50 markets: Each state has its own licensing, building setback requirements, bank collateral bans, and city/county approval hierarchies. Singer points out: "There is no real distribution infrastructure and contract manufacturing system. You cannot rent production lines like in ordinary CPG (consumer packaged goods), because running the equipment line once produces 10 times the inventory of the entire state's demand." This leads the industry to still be in the 'infrastructure stage'.
| Dimension |
Legal THC Market |
Illegal THC Market |
CBD Market |
| Size (Hundred Million USD) |
10-200 |
60-700 |
2-40 |
| Regulatory Status |
State-level regulation, with testing |
Completely unregulated |
Federally unregulated, FDA avoidance |
| Distribution |
Self-built within state |
Underground network |
Online/retail, but no standardization |
| Dosage Controllability |
Medium (with testing) |
Very low |
Very low (6% bioavailability) |
3. Competition Logic: Some Scale is a Liability
Singer believes that the biggest competitive advantage in the cannabis industry today is "federal illegality" itself—it keeps big brands out, allowing innovators to start small and build a true moat. He warns against being deceived by the industry narrative that "scale is justice."
- Why big brands can't enter: ① Brands like Coke cannot risk their existing business lines; ② Distribution channels differ—cannabis is sold only through dispensaries (similar to jewelry stores), not on traditional retail shelves; ③ Big brands' production lines are "national scale"—running them for a small market (e.g., a single state) leads to overproduction and uncontrolled marginal costs; ④ Even a minor issue (e.g., aluminum can liners absorbing THC), if handled with a big company's process (treating a $2M problem as a $2B problem), can cause months of delays.
- "No brand, only consistency": Singer's view is that a brand without consistency is just a logo. He gives an example: making cannabinoids water-soluble (to enter the low-fat beverage system) took years of R&D investment, and required solving scientific problems such as suspension stability, pH, and shelf-life degradation—these are "infrastructure-level moats" that cannot be bought with money through advertising.
- Gross margin structure: At Stillwater Brands (THC business), gross margin is approximately 30-40% EBITDA. The sales team has only 3 people, covering 360 dispensaries (serving a state with a population of about 8 million). Since Google and Facebook refuse to accept THC/CBD advertising, there is no path to "burning cash on performance marketing." Marketing costs are high (requiring third-party sponsored content + redirect placements), yet even so, a 35% EBIT margin is achievable.
4. Future Projection: Regulatory Timeline, Falsification Signals, and Validation Conditions
Singer is cautiously optimistic about regulatory progress, but he clearly lays out two key timelines and warns that the prevailing market narrative ("federal legalization will fix everything overnight") is a dangerous fantasy.
- THC regulation: He believes 2021 (after the election) is a critical window. "If THC and CBD could get to where they are today under the extreme anti-cannabis administrations of former Attorney General Sessions and Bill Barr, imagine what could happen with someone who isn't determined to destroy it." He expects that decriminalization may be achieved in the next 24 months, followed by legalization. But "At every juncture over the past four years, someone has made this prediction, so concrete administrative action must be seen to confirm."
- CBD regulation: The FDA claims it needs 3–5 years. Singer argues, "A public health regulator claiming 'insufficient information' and doing nothing when 20–40 million people consume a completely unregulated product daily is unacceptable. What you need is a regulator willing to regulate." He provides a validation condition: If the next administration appoints an active regulator, CBD regulation could be established as early as 2021.
- Falsification signals: "If no clear regulatory push (such as banking access, FDA accepting a CBD regulatory role) emerges after the election, then all the above timelines are invalid." He also notes that even federal legalization will not change everything instantly — retail, distribution, and production systems will need to be rebuilt one by one. He cites the concept of "philosophical friction": models at different scales are completely different; what works in Colorado may be entirely ineffective in Michigan.
5. Investment Discipline: Structure Over Intuition, Self-Defense in an Era of Fraud
Singer believes we are currently in a 'golden age of fraud' because 'there is no penalty for lying.' He advises investors to use structured decision-making to avoid over-reliance on founder intuition.
- Structured decision-making framework: Singer cites the CIA's internal decision-making methodology, arguing that investors should pursue 'prediction ranges rather than point predictions.' He advocates for 'structured decision-making'—examining the gap between a candidate's integrity, descriptive ability, and execution ability, and using 'counterfactual exercises' to avoid narrative bias. He emphasizes, 'I intuitively like this person' is luck, not a repeatable system.'
- Roots of the 'golden age of fraud': 'We have no penalty for liars, and from top to bottom we reward 'braggarts.'' He believes that deifying founders as 'extraordinary aliens' is a harmful form of idol worship. 'Most of the time, founders are actually terrible human beings, carried by capable people within the company while being treated like childish kids.' He hopes that investors will not be fooled by 'founder charisma' and instead focus on whether the organization 'treats employees as people'—not demanding cult-like loyalty, allowing employees to go home and enjoy their families.
Mentioned Subjects
| Subject |
Guest Sentiment |
Key Data |
| Stillwater Brands |
Bullish (founder perspective, positive) |
360 pharmacies, serving 8 million population; EBITDA 30-40% |
| Caliper Foods |
Bullish (technology R&D platform) |
Focused on water-soluble cannabinoid technology, invested years of R&D |
| Ripple (product line) |
Positive (company growth engine) |
Water-soluble powder, takes effect in 5 minutes, converted from "waste" |
| Coke / Pepsi |
Risk warning (restricted entry) |
Cannot enter due to federal illegality, production scale mismatch |
| Constellation Brands |
Risk warning (overinvestment) |
$2M aluminum can lining issue treated as $2B, causing delays |
| Uber / Lyft |
Neutral (regulatory-driven case) |
Legal interpretation of independent contractor relationship is business foundation |
Judgments Worth Remembering
1. The Regulatory Unlock Law (Singer's original framework): The best VC opportunity = huge known demand + regulatory unlock event. Technology itself does not create markets; law is the competitive platform. (Cases: spectrum auctions, bankruptcy law, DSHEA, Section 230)
2. The "Dose Trichotomy": THC at sub-5 mg (anxiolytic), 5-15 mg (anesthetic), and above 50 mg (hallucinogenic) constitutes three different drugs. "Low doses (1-2 mg) have no reason to be regulated as cannabis." This dosing framework directly challenges regulatory and market perceptions.
3. The F1 Rules Analogy: Rule changes force all participants back into the "first 95% of innovation space", rather than competing on the marginal efficiency of the last 5%. "Economic vitality is not where you optimize to the extreme, but where you start over."
4. "A brand without consistency is just a logo": In the infrastructure phase, quality and capability are the moat, not the brand. "Since Coke can't sell on our shelves—great—then they can't sell ours on their shelves either."
5. "The reward for lying outweighs integrity" (regarding the CBD industry): "When regulators don't regulate, self-regulation is asking for trouble." He argues that regulators should "establish rules first, then improve," rather than waiting for perfect information.
6. "The Golden Age of Fraud": "There is no penalty for lying. From top to bottom, braggarts are rewarded." He advises investors to adopt structured decision-making (CIA methodology) rather than intuition.
7. "Founders are not aliens": "Most of the time, founders are actually terrible humans, carried by capable people within the company." He opposes founder worship, emphasizing that organizational health is more important than "founder charisma."
8. The counterfactual lesson from the "Ripple story": "Success was not inevitable; Ripple grew out of scrap. We had three other directions we could have taken, any one of which could have failed." — "Never tell only the success narrative; tell the three other stupid ideas you abandoned."